|
Ranibizumab (anti-VEGFA)
|
Ab176067-1mg
|
无载体, 重组, ExactAb™, 低内毒素, 无叠氮钠, 已验证, 无动物源, ≥95%(SDS-PAGE&SEC-HPLC), 见COA |
347396-82-1 |
1mg
|
¥ 7129.9
|
现货 |
|
0 |
阿拉丁 |
|
Ranibizumab (anti-VEGFA)
|
Ab176067-10mg
|
无载体, 重组, ExactAb™, 低内毒素, 无叠氮钠, 已验证, 无动物源, ≥95%(SDS-PAGE&SEC-HPLC), 见COA |
347396-82-1 |
10mg
|
¥ 28639.9
|
期货,请咨询 |
|
0 |
阿拉丁 |
|
Ranibizumab (anti-VEGFA)
|
Ab176067-100μg
|
无载体, 重组, ExactAb™, 低内毒素, 无叠氮钠, 已验证, 无动物源, ≥95%(SDS-PAGE&SEC-HPLC), 见COA |
347396-82-1 |
100μg
|
¥ 1143.92
|
现货 |
|
0 |
阿拉丁 |
|
Recombinant EGFR Antibody (Biotin)
|
Ab176025-10μg
|
ExactAb™, 重组, 已验证, 无叠氮钠, 1.0 mg/mL |
N/A |
10μg
|
¥ 639.92
|
现货 |
|
0 |
阿拉丁 |
|
Recombinant EGFR Antibody (Biotin)
|
Ab176025-100μg
|
ExactAb™, 重组, 已验证, 无叠氮钠, 1.0 mg/mL |
N/A |
100μg
|
¥ 3999.9
|
现货 |
|
0 |
阿拉丁 |
|
Recombinant EGFR Antibody (APC)
|
Ab176024-25T
|
ExactAb™, 重组, 已验证, 无叠氮钠, Ex:650nm, Em:660nm, 5μL/test |
N/A |
25T
|
¥ 719.92
|
现货 |
|
0 |
阿拉丁 |
|
Recombinant EGFR Antibody (APC)
|
Ab176024-10T
|
ExactAb™, 重组, 已验证, 无叠氮钠, Ex:650nm, Em:660nm, 5μL/test |
N/A |
10T
|
¥ 399.92
|
现货 |
|
0 |
阿拉丁 |
|
Recombinant EGFR Antibody (APC)
|
Ab176024-100T
|
ExactAb™, 重组, 已验证, 无叠氮钠, Ex:650nm, Em:660nm, 5μL/test |
N/A |
100T
|
¥ 2239.92
|
现货 |
|
0 |
阿拉丁 |
|
Recombinant EGFR Antibody (PE)
|
Ab176023-25T
|
ExactAb™, 重组, 已验证, 无叠氮钠, Ex:565nm, Em:575nm, 5μL/test |
N/A |
25T
|
¥ 719.92
|
现货 |
|
0 |
阿拉丁 |
|
Recombinant EGFR Antibody (PE)
|
Ab176023-10T
|
ExactAb™, 重组, 已验证, 无叠氮钠, Ex:565nm, Em:575nm, 5μL/test |
N/A |
10T
|
¥ 399.92
|
现货 |
|
0 |
阿拉丁 |
|
Recombinant EGFR Antibody (PE)
|
Ab176023-100T
|
ExactAb™, 重组, 已验证, 无叠氮钠, Ex:565nm, Em:575nm, 5μL/test |
N/A |
100T
|
¥ 2799.9
|
现货 |
|
0 |
阿拉丁 |
|
Recombinant EGFR Antibody (FITC)
|
Ab176022-25T
|
ExactAb™, 重组, 已验证, 无叠氮钠, Ex:498nm, Em:517nm, 5μL/test |
N/A |
25T
|
¥ 559.92
|
现货 |
|
0 |
阿拉丁 |
|
Recombinant EGFR Antibody (FITC)
|
Ab176022-10T
|
ExactAb™, 重组, 已验证, 无叠氮钠, Ex:498nm, Em:517nm, 5μL/test |
N/A |
10T
|
¥ 319.92
|
现货 |
|
0 |
阿拉丁 |
|
Recombinant EGFR Antibody (FITC)
|
Ab176022-100T
|
ExactAb™, 重组, 已验证, 无叠氮钠, Ex:498nm, Em:517nm, 5μL/test |
N/A |
100T
|
¥ 1999.9
|
现货 |
|
0 |
阿拉丁 |
|
Lemzoparlimab (anti-CD47)
|
Ab175995-100μg
|
无载体, 重组, ExactAb™, 低内毒素, 无叠氮钠, 已验证, 无动物源, ≥95%(SDS-PAGE&SEC-HPLC), 见COA |
2377483-71-9 |
100μg
|
¥ 831.92
|
现货 |
|
0 |
阿拉丁 |
|
Ulocuplumab (anti-CXCR4)
|
Ab175993-100μg
|
无载体, 重组, ExactAb™, 低内毒素, 无叠氮钠, 已验证, 无动物源, ≥95%(SDS-PAGE&SEC-HPLC), 见COA |
1375830-34-4 |
100μg
|
¥ 463.92
|
现货 |
|
0 |
阿拉丁 |
|
Alpaca IgG
|
Ab175970-100μg
|
无载体, ExactAb™, 无叠氮钠, 已验证, ≥85%, 见COA |
N/A |
100μg
|
¥ 259.9
|
期货,请咨询 |
|
0 |
阿拉丁 |
|
Tislelizumab (anti-PDCD1)
|
Ab175896-5mg
|
无载体, 重组, ExactAb™, 低内毒素, 无叠氮钠, 已验证, 无动物源, ≥95%(SDS-PAGE&SEC-HPLC), 见COA |
1858168-59-8 |
5mg
|
¥ 2999.9
|
现货 |
|
0 |
阿拉丁 |
|
Tislelizumab (anti-PDCD1)
|
Ab175896-1mg
|
无载体, 重组, ExactAb™, 低内毒素, 无叠氮钠, 已验证, 无动物源, ≥95%(SDS-PAGE&SEC-HPLC), 见COA |
1858168-59-8 |
1mg
|
¥ 1029.9
|
现货 |
|
0 |
阿拉丁 |
|
Tislelizumab (anti-PDCD1)
|
Ab175896-10mg
|
无载体, 重组, ExactAb™, 低内毒素, 无叠氮钠, 已验证, 无动物源, ≥95%(SDS-PAGE&SEC-HPLC), 见COA |
1858168-59-8 |
10mg
|
¥ 4799.9
|
期货,请咨询 |
|
0 |
阿拉丁 |
|
Tislelizumab (anti-PDCD1)
|
Ab175896-100μg
|
无载体, 重组, ExactAb™, 低内毒素, 无叠氮钠, 已验证, 无动物源, ≥95%(SDS-PAGE&SEC-HPLC), 见COA |
1858168-59-8 |
100μg
|
¥ 167.92
|
现货 |
|
0 |
阿拉丁 |
|
Glembatumumab (anti-GPNMB)
|
Ab175888-5mg
|
无载体, 重组, ExactAb™, 低内毒素, 无叠氮钠, 已验证, 无动物源, ≥95%(SDS-PAGE&SEC-HPLC), 见COA |
1020264-78-1 |
5mg
|
¥ 6079.9
|
现货 |
|
0 |
阿拉丁 |
|
Glembatumumab (anti-GPNMB)
|
Ab175888-1mg
|
无载体, 重组, ExactAb™, 低内毒素, 无叠氮钠, 已验证, 无动物源, ≥95%(SDS-PAGE&SEC-HPLC), 见COA |
1020264-78-1 |
1mg
|
¥ 2889.9
|
现货 |
|
0 |
阿拉丁 |
|
Glembatumumab (anti-GPNMB)
|
Ab175888-10mg
|
无载体, 重组, ExactAb™, 低内毒素, 无叠氮钠, 已验证, 无动物源, ≥95%(SDS-PAGE&SEC-HPLC), 见COA |
1020264-78-1 |
10mg
|
¥ 9749.9
|
期货,请咨询 |
|
0 |
阿拉丁 |